Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Industry Wants More Guidance On Demonstrating Equivalence Of Drug-Device Combinations

Executive Summary

Firms want US FDA to better address how generic drug manufacturers can demonstrate similarity to innovator drug-device combination products.

You may also be interested in...



Generic Combination Products May Be Permitted Delivery Device Variations

But US FDA officials say brand vs. generic product differences won't be appropriate in all cases and patient misuse remains a concern.

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

New FDA Commissioner tells employees that 'too many consumers are priced out of medicines they need' and that FDA must take meaningful steps to get lower cost alternatives to market.

Advair Generic: Mylan Takes Issue With US FDA's 'Major' Concerns

Dispute over analysis of inhaler device could delay launch of competitor to GSK's franchise until 2018; FDA's complete response letter to Mylan' deemed 'major.'

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

GB002072

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel